Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-01 06:05 am Unchanged |
2021-02-22 | 13D | Augmedix, Inc. AUGX |
Redmile Group LLC | 14,246,125 50.400% |
0 (Unchanged) |
Filing History |
| 2021-02-16 4:27 pm Purchase |
2020-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 2,647,696 7.200% |
2,647,696 (New Position) |
Filing History |
| 2021-02-16 4:11 pm Purchase |
2020-12-31 | 13G | Itamar Medical Ltd. ITMR |
Redmile Group LLC | 21,345,000 5.000% |
21,345,000 (New Position) |
Filing History |
| 2021-02-16 4:11 pm Sale |
2020-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Redmile Group LLC | 2,397,441 4.900% |
-603,200 (-20.10%) |
Filing History |
| 2021-02-16 4:11 pm Sale |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
Redmile Group LLC | 0 0.000% |
-3,430,529 (Position Closed) |
Filing History |
| 2021-02-16 4:11 pm Purchase |
2020-12-31 | 13G | Replimune Group, Inc. REPL |
Redmile Group LLC | 4,658,043 9.900% |
1,036,408 (+28.62%) |
Filing History |
| 2021-02-16 4:11 pm Purchase |
2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 2,846,125 7.300% |
2,846,125 (New Position) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
Redmile Group LLC | 209,783 9.900% |
209,783 (New Position) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
Redmile Group LLC | 2,720,489 6.100% |
2,720,489 (New Position) |
Filing History |
| 2021-02-16 4:10 pm Sale |
2020-12-31 | 13G | ImmunoGen, Inc. IMGN |
Redmile Group LLC | 10,528,179 5.600% |
-4,111,781 (-28.09%) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | HOOKIPA Pharma Inc. HOOK |
Redmile Group LLC | 265,390 9.900% |
76,138 (+40.23%) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Redmile Group LLC | 4,915,729 9.900% |
1,799,135 (+57.73%) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | Epizyme, Inc. EPZM |
Redmile Group LLC | 10,225,405 9.900% |
1,088,032 (+11.91%) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 314,545 9.900% |
94,780 (+43.13%) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Redmile Group LLC | 2,416,406 6.000% |
2,416,406 (New Position) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Yumanity Therapeutics, Inc. YMTX |
Redmile Group LLC | 96,221 6.600% |
96,221 (New Position) |
Filing History |
| 2021-02-16 4:09 pm Sale |
2020-12-31 | 13G | Wave Life Sciences Ltd. WVE |
Redmile Group LLC | 79,018 0.200% |
-3,247,475 (-97.62%) |
Filing History |
| 2021-02-16 4:09 pm Sale |
2020-12-31 | 13G | uniQure N.V. QURE |
Redmile Group LLC | 1,028,898 2.300% |
-1,524,427 (-59.70%) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | TCR2 Therapeutics Inc. TCRR |
Redmile Group LLC | 2,832,888 8.500% |
1,033,700 (+57.45%) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
Redmile Group LLC | 2,686,234 7.400% |
2,686,234 (New Position) |
Filing History |